Corporate News
- Cell MedX Corp. provides additional information on its observational clinical trial with diabetes and related conditions Copy January 30, 2018
- Cell MedX Corp. Assigned Legal Entity Identifier Number by Deutsche Börse Group January 29, 2018
- Cell MedX Corp. Completes its First Observational Clinical Trial and Observes Positive Results with Diabetes and Related Conditions January 24, 2018
- Cell MedX Corp. Appoints Dr. Terrance Owen as CEO and Director December 5, 2017
- Cell MedX Corp. Provides Corporate Update August 31, 2017
- Cell MedX Corp. Provides Update on its Clinical Observational Trial July 31, 2017
- Cell MedX Corp. Provides Corporate Update July 5, 2017
- Cell MedX Corp. Moves its Manufacturing to British Columbia, Canada April 26, 2017
- Cell MedX Corp. Announces FDA Registration and Update on Clinical Observational Study March 28, 2017
- Cell MedX Corp. Announces First Subjects Screened and Qualified for the Observational Clinical Trial March 9, 2017
Historical Press Releases
This website contains historical and archived press releases for Cell MedX Corp. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cell MedX Corp and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.